Jingky P Lozano-Kuehne (J P Lozano-Kuehne, Jingky P Lozan-Kuehne)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Small Cell Lung Cancer

Positron Emission Tomography

Epidermal Growth Factor Receptor

Top Venues

Nature communications

British journal of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, V Ferguson, Michael J Seckl
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 14 (1) (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, V Ferguson, Michael J Seckl
Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 14 (1) (2023)
Preetha Aravind, Sanjay Popat, Tara D Barwick, Neil Soneji, Mark Lythgoe, Katherina B Sreter, Jingky P Lozano-Kuehne, Mattias Bergqvist, Neva Patel, Eric O Aboagye, Laura M Kenny
A Subset of Non-Small Cell Lung Cancer Patients Treated with Pemetrexed Show 18 F-Fluorothymidine "Flare" on Positron Emission Tomography. Cancers 15 (14) (2023)
Raoul Charles Coombes, P D Badman, Jingky P Lozano-Kuehne, X Liu, Iain R J Macpherson, I Zubairi, Richard D Baird, Nitzan Rosenfeld, Javier García Corbacho, Nicola Cresti, R Plummer, A Armstrong, R Allerton, Dónal Landers, H Nicholas, L McLellan, A Lim, Florent Mouliere, Olivier E Pardo, Michael J Seckl
Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nature communications 13 (1) (2022)
Sebastian Trousil, Patrizia Lee, Robert J Edwards, Lynn Maslen, Jingky P Lozano-Kuehne, Ramya Ramaswami, Eric O Aboagye, Stephen Clarke, Christopher Liddle, Rohini Sharma
Altered cytochrome 2E1 and 3A P450-dependent drug metabolism in advanced ovarian cancer correlates to tumour-associated inflammation. British journal of pharmacology 176 (18) (2019)